AS 50% eye drops 8*1 — Competitive Intelligence Brief

AS 50% eye drops 8*1 (AS 50% eye drops 8*1) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic agent. Area: Ophthalmology.

marketed Osmotic agent Ophthalmology Biologic

Target snapshot

AS 50% eye drops 8*1 (AS 50% eye drops 8*1) — Seref istek. AS 50% eye drops provide osmotic dehydration of corneal edema by drawing fluid from the cornea into the anterior chamber.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
AS 50% eye drops 8*1 TARGET	AS 50% eye drops 8*1	Seref istek	marketed	Osmotic agent
Icodextrin Peritoneal Dialysis Solution	Icodextrin Peritoneal Dialysis Solution	RenJi Hospital	marketed	Osmotic agent for peritoneal dialysis
Sodium Chloride [3%]	Sodium Chloride [3%]	Fundacion Clinica Valle del Lili	marketed	Electrolyte solution / Osmotic agent
Hypertonic Saline 7%	Hypertonic Saline 7%	The Hospital for Sick Children	marketed	Osmotic agent
Hypertonic saline 3% bolus administration	Hypertonic saline 3% bolus administration	Université de Sherbrooke	marketed	Osmotic agent
NaCl 7.5%	NaCl 7.5%	Aristotle University Of Thessaloniki	marketed	Osmotic agent / Electrolyte solution
Saline Solution, Hypertonic	Saline Solution, Hypertonic	Medical University of Silesia	marketed	Osmotic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic agent class)

1. Arbor Pharmaceuticals, Inc. · 1 drug in this class
2. Innogene Kalbiotech Pte. Ltd · 1 drug in this class
3. Medical University of Silesia · 1 drug in this class
4. Seref istek · 1 drug in this class
5. The Hospital for Sick Children · 1 drug in this class
6. Université de Sherbrooke · 1 drug in this class